tom beer, md on the data presented at asco gu20 investigating atezolizumab and cabozantinib in mcrpc

Published 4 years ago • 159 plays • Length 0:47

Download video MP4
Download video MP3

Similar videos

0:51

rana mckay, md, elaborates on presented data investigating atezolizumab and cabozantinib in mcrpc
1:32

bradley mcgregor, md, shares presented data investigating atezolizumab and cabozantinib in mcrpc
0:42

tom beer, md, on impressions of the card study investigating cabazitaxel in mcrpc patients
1:01

oliver sartor, md, elaborates on presented data investigating atezolizumab and cabozantinib in mcrpc
0:37

tanya dorff, md, elaborates on data investigating atezolizumab and cabozantinib in prostate cancer
1:10

daniel petrylak, md, on investigating atezolizumab and cabozantinib relating to prostate cancer
0:57

tom beer, md, shares impressions of the titan study invesigating 1st line therapy in mcrpc patients
1:12

tom beer, md, describes use of dna repair markers when determining treatment of prostate cancer
29:55

pancreatic cancer ‐ dr tom cox
19:24

m0 crpc: treatment options and emerging concepts
4:32

prostate cancer chemotherapy basics | ask a prostate expert, mark scholz, md
0:42

oliver sartor, md, on impressions of the card study investigating the role of cabazitaxel in mcrpc
0:47

tanya dorff, md, on impressions of the card study investigating the role of cabazitaxel in mcrpc
0:23

tanya dorff, md, shares thoughts of the optimal sequence of atezolizumab and sip-t in mcrpc
2:19

tomasz m. beer md, facp, on the efficacy of abiraterone enzalutamide in mcrpc
0:44

tom beer, md, explains whether pfs2 is a legitimate endpoint in prostate cancer clinical trials
2:03

tomasz m. beer md, facp, tells us about the enzamet study in mhspc
1:52

tomasz m. beer, md, discusses the central themes regarding prostate cancer here at asco 2018
4:36

expert report on latest data in the management of metastatic prostate cancer from asco 2022
1:41

faces of prostate cancer: dr. tomasz beer
1:33

tomasz m. beer, md, on how immunotherapy is being integrated into crpc treatment algorithms
3:21

researcher comment: the cosmic-021 mcrpc cohort | neeraj agarwal

Clip.africa.com - Privacy-policy